Strategies for the design of hepatoselective glucokinase activators to treat type 2 diabetes-Reference-Cited by-同舟云学术

Strategies for the design of hepatoselective glucokinase activators to treat type 2 diabetes

Published:2013-01-06 Issue:3 Volume:8 Page:319-330
ISSN:1746-0441
Container-title:Expert Opinion on Drug Discovery
language:en
Short-container-title:Expert Opinion on Drug Discovery

Author:

Pfefferkorn Jeffrey A

Publisher

Informa UK Limited

Subject

Drug Discovery

Link

http://www.tandfonline.com/doi/pdf/10.1517/17460441.2013.748744

Reference56 articles.

1. Diabetes in numbers

2. Lebovitz HE. Management of Hyperglycemia with oral antihyperglycemic agents in type 2 diabetes. 14th edition. Lippincott Williams & Wilkins, New York; 2004. p. 687-710

3. New Drugs for Type 2 Diabetes Mellitus

4. Glucokinase activators as potential antidiabetic agents possessing superior glucose lowering efficacies

5. Assessing the potential of glucokinase activators in diabetes therapy

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Insights to the emerging potential of glucokinase activators as antidiabetic agent;Pharmaceutical Patent Analyst;2024-09-11

2. Transporter-Mediated Drug Delivery;Molecules;2023-01-24

3. Small Molecule Allosteric Activators of Human Glucokinase for the Treatment of Type 2 Diabetes: Current Status and Challenges;Current Drug Discovery Technologies;2022-07

4. Recent Advances Regarding the Physiological Functions and Biosynthesis of D-Allulose;Frontiers in Microbiology;2022-04-14

5. Targeting human Glucokinase for the treatment of type 2 diabetes: an overview of allosteric Glucokinase activators;Journal of Diabetes & Metabolic Disorders;2022-03-11